For most patients, B12 injections do not cause any significant long-term health concerns
Shimyn Slomovic, Ph.D., a postdoctoral fellow on Collins team
This makes it uniquely valuable for researchers studying comprehensive metabolic regulation, allowing investigation of both incretin-dependent and incretin-independent appetite control mechanisms in a single model
0.5 mg, n = 2 and one participant reduced to 1.7 mg before withdrawing)
SURMOUNT-1 Tirzepatide in Participants With Obesity or Overweight
While Ipamorelin is generally well-tolerated with minimal adverse effects reported, Tesamorelin may cause injection site reactions, transient increases in blood sugar levels, and potentially exacerbate pre-existing conditions such as diabetes